Organizational Mission

Keystone Symposia will serve as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops held at venues that create an environment conducive to information exchange, generation of new ideas, and acceleration of discoveries that benefit society.

FY17 Program Accomplishments

Keystone Symposia's FY17 year (July 2016 — June 2017) featured 60 conferences across a diverse range of the life sciences that attracted the participation of 13,864 scientists from 90 countries. Sixty-five percent of participants were affiliated with academia, with the remainder coming from industry, government and nonprofit/nongovernment organizations; nine percent of participants did not disclose their affiliation. FY17 student and postdoc participation was 35%. The majority of attendees (67%) who disclosed year of birth were under 45 years of age. In general, attendee demographics were similar to those of the previous two years.

Some notable achievements and milestones included:

  • Keystone Symposia awarded 365 scholarships for conference attendance to deserving graduate students and postdoctoral fellows, funded by its own operating fund as well as generous donor and grant support.

  • Women were well-represented among scholarship recipients (51%). Seventeen scholarships were awarded to students and postdoctoral fellows from underrepresented backgrounds.

  • Global Health Travel Awards funded by the Bill & Melinda Gates Foundation enabled 211 investigators and clinicians from developing countries to attend meetings in the 2017 Keystone Symposia Global Health Series.

  • Attendees completing the exit surveys gave high ratings for professional development opportunities at Keystone Symposia conferences regardless of career stage, affiliation or meeting role. Seventy-six percent agreed that they made a useful contact at the conference they attended that will lead to a collaboration or sharing of information, data or techniques. Similarly, respondents recognized that the conference had the potential to impact their research regardless of career stage or affiliation. Eighty-five percent of attendees agreed that the conference facilitated interactions between junior and senior investigators.

  • Exit survey respondents reported very high ratings for the scientific content of the conferences regardless of age, region, affiliation or occupation, continuing the same trend observed over the last few years. Ninety-three percent of participants rated the scientific content "Excellent" or "Very Good."

  • According to exit survey responses, 46% of those participating were attending a Keystone Symposia conference for the first time.

  • Keystone Symposia expanded outreach beyond the 60 face-to-face conferences via public lectures for the Summit County, Colorado community and online “Virtual Keystone Symposia” events:

    • Noncoding RNAs: Current and Future Trends, an ePanel livestream featuring Drs. Frank Slack (moderator), Amy Pasquinelli, Pier Paolo Pandolfi and Anita Seto as panelists and broadcast to participants around the world.

    • Health Disparities: The Intersection of Science and Race, an online live panel discussion with Q&A featuring Drs. Irelene Ricks (moderator), Russell DeBose-Boyd, Glenn Simmons Jr., Amanda Marie James and Lovell Jones as panelists and broadcast to participants around the world.

    • HIV: Antibody Functions Beyond Neutralization, an online ePanel featuring Drs. Gabriella Scarlatti (moderator), Guido Ferrari, Ann J. Hessell and Robin Shattock as panelists and broadcast to participants around the world.

    • Malaria: From Innovation to Eradication, an online live panel discussion with Q&A featuring Drs. Marcel Tanner (moderator), Sarah K. Volkman, Marcus Lacerda, Jetsumon Prachumsri, Salim Abdulla, Silvie Huijben, Gawrie Loku Galappaththy, Elizabeth Chizema Kawesha and Vladimir Corredor as panelists and broadcast to participants around the world.

See Program Accomplishments from prior years